Back

Computed tomography-derived myocardial extracellular volume as a prognosis predictor in patients with severe aortic stenosis.

19 May 2024 (09:00 - 12:00)
Organised by: Logo
Congress Presentation Part of: Cardiac computed tomography (CT) Valvular Heart Disease Open Access International Conference on Nuclear Cardiology and Cardiac CT 2024 European Association of Cardiovascular Imaging (EACVI)

About the speaker

Photo
Doctor Rita Reis Santos

Hospital Santa Cruz, Lisbon (Portugal)

5 More presentations in this session

Presentation thumbnail
Prognostic implications of myocardial perfusion defects: establishing cutoff values through dynamic computed tomography in patients with known or suspected coronary artery disease.
Doctor C. Gonzalez Freixa (Barcelona, ES)
Abstract
Presentation thumbnail
Association of longitudinal hemodynamic phenotypes of coronary artery disease with myocardial perfusion and myocardial blood flow
Doctor Z. Steffek (Zurich, CH)
Abstract
Presentation thumbnail
Opportunistic coronary calcium screening in patients undergoing procedural planning for catheter ablation of atrial fibrillation
Doctor A. Aguiar Neves (Vila Nova de Gaia, PT)
Abstract
Presentation thumbnail
Comparative analysis of volume and distribution of body fat in patients with lymphoma before and after chemotherapy
Doctor S. Soares Brandao (Recife, BR)
Abstract
Presentation thumbnail
Calcium hides the clue: unraveling the diagnostic value of early coronary calcium scoring in cardiac arrest survivors
Doctor A. Martins (Lisbon, PT)
Abstract

Access the full session

Session thumbnail
Cardiac computed tomography (CT)

The Event

Event poster

International Conference on Nuclear Cardiology and Cardiac CT 2024

19 May - 21 May 2024
You may be interested in
thumbnail
Congress Presentation
Aortic valve disease: when and how to integrate CT for optimal planning
thumbnail
Congress Presentation
When to use cardiac magnetic resonance in aortic stenosis
thumbnail
Congress Presentation
How to use CT to guide treatment in patients with heart valve disease

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources